| EC5 | Name: | (2R)-2-[5-CYCLOPROPYL-6-(HYDROXYSULFANYL)-4-(NAPHTHALEN-1-YLMETHYL)-2-OXOPYRIDIN-1(2H)-YL]-3-PHENYLPROPANOIC ACID | Formula: | C28 H25 N O4 S | SMILES: | O=C(O)C(N1C(SO)=C(C(=CC1=O)Cc3c2ccccc2ccc3)C4CC4)Cc5ccccc5 | InChi: | InChI=1S/C28H25NO4S/c30-25-17-22(16-21-11-6-10-19-9-4-5-12-23(19)21)26(20-13-14-20)27(34-33)29(25)24(28(31)32)15-18-7-2-1-3-8-18/h1-12,17,20,24,33H,13-16H2,(H,31,32)/t24-/m0/s1 | Definition date: | 2010-05-30 | Last modified: | 2011-06-04 | Identifier: | (2R)-2-[5-cyclopropyl-6-(hydroxysulfanyl)-4-(naphthalen-1-ylmethyl)-2-oxopyridin-1(2H)-yl]-3-phenylpropanoic acid |
|
| ECA | Name: | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3-DIHYDROXYBENZAMIDE) | Formula: | C30 H27 N3 O9 | SMILES: | O=C(c1cccc(O)c1O)NCc2cc(cc(c2)CNC(=O)c3cccc(O)c3O)CNC(=O)c4cccc(O)c4O | InChi: | InChI=1S/C30H27N3O9/c34-22-7-1-4-19(25(22)37)28(40)31-13-16-10-17(14-32-29(41)20-5-2-8-23(35)26(20)38)12-18(11-16)15-33-30(42)21-6-3-9-24(36)27(21)39/h1-12,34-39H,13-15H2,(H,31,40)(H,32,41)(H,33,42) | Definition date: | 2006-03-16 | Last modified: | 2011-06-04 | Identifier: | N,N',N''-(benzene-1,3,5-triyltrimethanediyl)tris(2,3-dihydroxybenzamide) |
|
| ECS | Name: | 2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE | Formula: | C18 H24 O3 | SMILES: | Oc1cc4c(cc1O)C3CCC2(C(CCC2O)C3CC4)C | InChi: | InChI=1S/C18H24O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,19-21H,2-7H2,1H3/t11-,12+,14-,17-,18-/m0/s1 | Definition date: | 2005-07-12 | Last modified: | 2011-06-04 | Identifier: | (9beta,13alpha,14beta,17alpha)-estra-1,3,5(10)-triene-2,3,17-triol |
|
| EDA | Name: | 3-[2-DEOXY-RIBOFURANOSYL]-3H-1,3,4,5A,8-PENTAAZA-AS-INDACENE-5'-MONOPHOSPHATE | Formula: | C12 H14 N5 O6 P | SMILES: | O=P(O)(O)OCC4OC(n3cnc1c3ncn2ccnc12)CC4O | InChi: | InChI=1S/C12H14N5O6P/c18-7-3-9(23-8(7)4-22-24(19,20)21)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18H,3-4H2,(H2,19,20,21)/t7-,8+,9+/m0/s1 | Definition date: | 2000-04-28 | Last modified: | 2011-06-04 | Identifier: | 3-(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purine |
|
| EDB | Name: | 2-{3-[(5E)-5-{[(2,3-dichlorophenyl)carbamoyl]imino}-3-thiophen-2-yl-2,5-dihydro-1H-pyrazol-1-yl]phenyl}acetamide | Formula: | C22 H17 Cl2 N5 O2 S | SMILES: | Clc1cccc(c1Cl)NC(=O)/N=C3/N(NC(c2sccc2)=C3)c4cc(ccc4)CC(=O)N | InChi: | InChI=1S/C22H17Cl2N5O2S/c23-15-6-2-7-16(21(15)24)26-22(31)27-20-12-17(18-8-3-9-32-18)28-29(20)14-5-1-4-13(10-14)11-19(25)30/h1-10,12,28H,11H2,(H2,25,30)(H,26,31)/b27-20+ | Definition date: | 2010-06-29 | Last modified: | 2011-06-04 | Identifier: | 2-{3-[(5E)-5-{[(2,3-dichlorophenyl)carbamoyl]imino}-3-(thiophen-2-yl)-2,5-dihydro-1H-pyrazol-1-yl]phenyl}acetamide |
|
| EDE | Name: | EDEINE B | Formula: | C34 H59 N11 O10 | SMILES: | O=C(NCCCNCCCCC(=[N@H])N)CNC(=O)CC(O)C(N)CCCC(C(=O)O)NC(=O)C(NC(=O)C(O)CNC(=O)CC(N)c1ccc(O)cc1)CN | InChi: | InChI=1S/C34H59N11O10/c35-17-25(45-33(53)27(48)18-42-29(49)15-23(37)20-8-10-21(46)11-9-20)32(52)44-24(34(54)55)6-3-5-22(36)26(47)16-30(50)43-19-31(51)41-14-4-13-40-12-2-1-7-28(38)39/h8-11,22-27,40,46-48H,1-7,12-19,35-37H2,(H3,38,39)(H,41,51)(H,42,49)(H,43,50)(H,44,52)(H,45,53)(H,54,55)/t22-,23-,24+,25-,26+,27-/m0/s1 | Definition date: | 2001-04-03 | Last modified: | 2011-06-04 | Identifier: | (2R,6S,7R)-6-amino-2-({3-amino-N-[(2S)-3-{[(3S)-3-amino-3-(4-hydroxyphenyl)propanoyl]amino}-2-hydroxypropanoyl]-L-alanyl}amino)-9-({2-[(3-{[(5E)-5-amino-5-iminopentyl]amino}propyl)amino]-2-oxoethyl}amino)-7-hydroxy-9-oxononanoic acid |
|
| EDR | Name: | EDROPHONIUM ION | Formula: | C10 H16 N O | SMILES: | Oc1cccc(c1)[N+](C)(CC)C | InChi: | InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | N-ethyl-3-hydroxy-N,N-dimethylanilinium |
|
| EDT | Name: | {[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID | Formula: | C10 H16 N2 O8 | SMILES: | O=C(O)CN(CC(=O)O)CCN(CC(=O)O)CC(=O)O | InChi: | InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20) | Definition date: | 2003-01-16 | Last modified: | 2011-06-04 | Identifier: | 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid |
|
| EEB | Name: | URIDINE-DIPHOSPHATE-3(N-ACETYLGLUCOSAMINYL)BUTYRIC ACID | Formula: | C21 H33 N3 O19 P2 | SMILES: | O=P(OC1OC(C(O)C(OC(C(=O)O)CC)C1NC(=O)C)CO)(O)OP(=O)(O)OCC3OC(N2C=CC(=O)NC2=O)C(O)C3O | InChi: | InChI=1S/C21H33N3O19P2/c1-3-9(19(31)32)39-17-13(22-8(2)26)20(41-10(6-25)15(17)29)42-45(36,37)43-44(34,35)38-7-11-14(28)16(30)18(40-11)24-5-4-12(27)23-21(24)33/h4-5,9-11,13-18,20,25,28-30H,3,6-7H2,1-2H3,(H,22,26)(H,31,32)(H,34,35)(H,36,37)(H,23,27,33)/t9-,10-,11-,13-,14-,15-,16-,17-,18-,20-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}butanoic acid (non-preferred name) |
|
| EED | Name: | (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL | Formula: | C20 H28 O3 | SMILES: | Oc1cc4c(cc1)C3C(CC2(C(CCC2O)C3CC4)C)COC | InChi: | InChI=1S/C20H28O3/c1-20-10-13(11-23-2)19-15-6-4-14(21)9-12(15)3-5-16(19)17(20)7-8-18(20)22/h4,6,9,13,16-19,21-22H,3,5,7-8,10-11H2,1-2H3/t13-,16+,17+,18+,19-,20+/m1/s1 | Definition date: | 2007-07-11 | Last modified: | 2011-06-04 | Identifier: | (9beta,11alpha,13alpha,14beta,17alpha)-11-(methoxymethyl)estra-1(10),2,4-triene-3,17-diol |
|
| EES | Name: | 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL | Formula: | C13 H9 Cl N2 O2 | SMILES: | Clc1c3cc(O)ccc3nn1c2ccc(O)cc2 | InChi: | InChI=1S/C13H9ClN2O2/c14-13-11-7-10(18)5-6-12(11)15-16(13)8-1-3-9(17)4-2-8/h1-7,17-18H | Definition date: | 2007-07-11 | Last modified: | 2011-06-04 | Identifier: | 3-chloro-2-(4-hydroxyphenyl)-2H-indazol-5-ol |
|
| EEU | Name: | ESTRADIOL-PYRIDINIUM TETRAACETIC ACID | Formula: | C35 H41 N3 O10 | SMILES: | C[C]12CC[CH]3[CH](CCc4cc(O)ccc34)[CH]1CC[C]2(O)C#Cc5cc(CN(CC(O)=O)CC(O)=O)nc(CN(CC(O)=O)CC(O)=O)c5 | InChi: | InChI=1S/C35H41N3O10/c1-34-9-7-27-26-5-3-25(39)14-22(26)2-4-28(27)29(34)8-11-35(34,48)10-6-21-12-23(15-37(17-30(40)41)18-31(42)43)36-24(13-21)16-38(19-32(44)45)20-33(46)47/h3,5,12-14,27-29,39,48H,2,4,7-9,11,15-20H2,1H3,(H,40,41)(H,42,43)(H,44,45)(H,46,47)/t27-,28-,29+,34+,35+/m1/s1 | Definition date: | 2011-02-24 | Last modified: | 2011-06-04 | Identifier: | 2-[[6-[(bis(carboxymethyl)amino)methyl]-4-[2-[(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]pyridin-2-yl]methyl-(carboxymethyl)amino]ethanoic acid |
|
| EFP | Name: | N-{1-[cis-3-(acetylamino)cyclobutyl]-1H-imidazol-4-yl}-2-(4-methoxyphenyl)acetamide | Formula: | C18 H22 N4 O3 | SMILES: | O=C(NC3CC(n1cc(nc1)NC(=O)Cc2ccc(OC)cc2)C3)C | InChi: | InChI=1S/C18H22N4O3/c1-12(23)20-14-8-15(9-14)22-10-17(19-11-22)21-18(24)7-13-3-5-16(25-2)6-4-13/h3-6,10-11,14-15H,7-9H2,1-2H3,(H,20,23)(H,21,24)/t14-,15+ | Definition date: | 2009-07-30 | Last modified: | 2011-06-04 | Identifier: | N-{1-[cis-3-(acetylamino)cyclobutyl]-1H-imidazol-4-yl}-2-(4-methoxyphenyl)acetamide |
|
| EFQ | Name: | N-[1-(cis-3-hydroxycyclobutyl)-1H-imidazol-4-yl]-2-(4-methoxyphenyl)acetamide | Formula: | C16 H19 N3 O3 | SMILES: | O=C(Nc1ncn(c1)C2CC(O)C2)Cc3ccc(OC)cc3 | InChi: | InChI=1S/C16H19N3O3/c1-22-14-4-2-11(3-5-14)6-16(21)18-15-9-19(10-17-15)12-7-13(20)8-12/h2-5,9-10,12-13,20H,6-8H2,1H3,(H,18,21)/t12-,13+ | Definition date: | 2009-07-30 | Last modified: | 2011-06-04 | Identifier: | N-[1-(cis-3-hydroxycyclobutyl)-1H-imidazol-4-yl]-2-(4-methoxyphenyl)acetamide |
|
| EG1 | Name: | AMINOMETHYLENECARBONYLAMINODI(ETHYLOXY)ETHYLAMINOCARBONYLBENZENESULFONAMIDE | Formula: | C15 H24 N4 O6 S | SMILES: | O=S(=O)(N)c1ccc(C(=O)NCCOCCOCCNC(=O)CN)cc1 | InChi: | InChI=1S/C15H24N4O6S/c16-11-14(20)18-5-7-24-9-10-25-8-6-19-15(21)12-1-3-13(4-2-12)26(17,22)23/h1-4H,5-11,16H2,(H,18,20)(H,19,21)(H2,17,22,23) | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | N-(2-{2-[2-(glycylamino)ethoxy]ethoxy}ethyl)-4-sulfamoylbenzamide |
|
| EG2 | Name: | AMINODI(ETHYLOXY)ETHYLAMINOCARBONYLBENZENESULFONAMIDE | Formula: | C13 H21 N3 O5 S | SMILES: | O=S(=O)(N)c1ccc(C(=O)NCCOCCOCCN)cc1 | InChi: | InChI=1S/C13H21N3O5S/c14-5-7-20-9-10-21-8-6-16-13(17)11-1-3-12(4-2-11)22(15,18)19/h1-4H,5-10,14H2,(H,16,17)(H2,15,18,19) | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-4-sulfamoylbenzamide |
|
| EG3 | Name: | PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE | Formula: | C22 H30 N4 O6 S | SMILES: | O=S(=O)(N)c1ccc(cc1)C(=O)NCCOCCOCCNC(=O)C(N)Cc2ccccc2 | InChi: | InChI=1S/C22H30N4O6S/c23-20(16-17-4-2-1-3-5-17)22(28)26-11-13-32-15-14-31-12-10-25-21(27)18-6-8-19(9-7-18)33(24,29)30/h1-9,20H,10-16,23H2,(H,25,27)(H,26,28)(H2,24,29,30)/t20-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | N-{2-[2-(2-{[(4-sulfamoylphenyl)carbonyl]amino}ethoxy)ethoxy]ethyl}-L-phenylalaninamide |
|
| EIN | Name: | (1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID | Formula: | C17 H22 N O6 P S | SMILES: | O=P(O)(O)C(NS(=O)(=O)c2ccc(c1ccc(OC)cc1)cc2)C(C)C | InChi: | InChI=1S/C17H22NO6PS/c1-12(2)17(25(19,20)21)18-26(22,23)16-10-6-14(7-11-16)13-4-8-15(24-3)9-5-13/h4-12,17-18H,1-3H3,(H2,19,20,21)/t17-/m0/s1 | Definition date: | 2005-06-01 | Last modified: | 2011-06-04 | Identifier: | [(1S)-1-{[(4'-methoxybiphenyl-4-yl)sulfonyl]amino}-2-methylpropyl]phosphonic acid |
|
| EKO | Name: | 4-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole | Formula: | C18 H15 Cl3 N2 O | SMILES: | Clc1ccc(CO[CH](Cc2c[nH]cn2)c3ccc(Cl)cc3Cl)cc1 | InChi: | InChI=1S/C18H15Cl3N2O/c19-13-3-1-12(2-4-13)10-24-18(8-15-9-22-11-23-15)16-6-5-14(20)7-17(16)21/h1-7,9,11,18H,8,10H2,(H,22,23)/t18-/m1/s1 | Definition date: | 2009-09-02 | Last modified: | 2011-06-04 | Identifier: | 4-[(2R)-2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole |
|
| EL | Name: | ELLIPTICINE | Formula: | C17 H15 N2 | SMILES: | c1cccc4c1c2c(c(c3c(c2C)c[nH+]cc3)C)n4 | InChi: | InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3/p+1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | 5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium |
|
| EMB | Name: | METHYL-CARBAMIC ACID ETHYL ESTER | Formula: | C4 H9 N O2 | SMILES: | O=C(OCC)NC | InChi: | InChI=1S/C4H9NO2/c1-3-7-4(6)5-2/h3H2,1-2H3,(H,5,6) | Definition date: | 1999-10-22 | Last modified: | 2011-06-04 | Identifier: | ethyl methylcarbamate |
|
| EMR | Name: | N-AMINOETHYLMORPHOLINE | Formula: | C6 H14 N2 O | SMILES: | O1CCN(CCN)CC1 | InChi: | InChI=1S/C6H14N2O/c7-1-2-8-3-5-9-6-4-8/h1-7H2 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | 2-morpholin-4-ylethanamine |
|
| EN1 | Name: | (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid | Formula: | C9 H8 O4 | SMILES: | O=C(O)C(/O)=Cc1ccc(O)cc1 | InChi: | InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-5,10-11H,(H,12,13)/b8-5+ | Definition date: | 2009-09-11 | Last modified: | 2011-06-04 | Identifier: | (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid |
|
| ENE | Name: | (4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL | Formula: | C22 H30 O8 | SMILES: | O3C1C(OC(CO)C(O)C=CC1)C=CC4OC2C(O)C5OCC=CCC5OC2CC34 | InChi: | InChI=1S/C22H30O8/c23-11-19-12(24)4-3-6-13-14(28-19)7-8-15-17(27-13)10-18-22(30-15)20(25)21-16(29-18)5-1-2-9-26-21/h1-4,7-8,12-25H,5-6,9-11H2/b4-3-/t12-,13+,14-,15+,16-,17-,18+,19+,20+,21-,22+/m0/s1 | Definition date: | 2007-10-03 | Last modified: | 2011-06-04 | Identifier: | (4Z)-2,8:7,12:11,15:14,18:17,22-pentaanhydro-4,5,6,9,10,13,19,20,21-nonadeoxy-L-arabino-L-allo-L-allo-docosa-4,9,20-trienitol |
|
| ENP | Name: | ETHENO-NADP | Formula: | C17 H24 N5 O17 P3 | SMILES: | O=P(O)(O)OC4C(O)C(OC4n2c3ncn1ccnc1c3nc2)COP(=O)(O)OP(=O)(O)OCC5OC(O)C(O)C5O | InChi: | InChI=1S/C17H24N5O17P3/c23-10-7(37-17(26)12(10)25)3-34-41(30,31)39-42(32,33)35-4-8-11(24)13(38-40(27,28)29)16(36-8)22-6-19-9-14-18-1-2-21(14)5-20-15(9)22/h1-2,5-8,10-13,16-17,23-26H,3-4H2,(H,30,31)(H,32,33)(H2,27,28,29)/t7-,8-,10-,11-,12-,13-,16-,17-/m1/s1 | Definition date: | 2001-12-06 | Last modified: | 2011-06-04 | Identifier: | [(2R,3R,4R,5R)-3-hydroxy-5-(3H-imidazo[2,1-i]purin-3-yl)-4-(phosphonooxy)tetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-3,4,5-trihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|